Portal Biotech
Builds nanopore instruments that sequence full-length proteins one molecule at a time.
portalbiotech.com ↗Why it's here
Raised a $35M Series A led by the NATO Innovation Fund and Earlybird in June 2025.
source: nif.fund- Focus
- Protein sequencing
- Founded
- 2021
- Latest round
- Series A, $35M, Jun 2025
- Staff (Companies House accounts)
- 11, average over the period to 31 Mar 2025source: find-and-update.company-information.service.gov.uk
- London office
- Scale Space, 58 Wood Lane, White City, London W12 7RZ, Hammersmith and Fulham W12 7RZsource: portalbiotech.com
- London presence
- HQsource: jobs.nif.fund
- Investors
- Earlybird (lead), NATO Innovation Fund (lead), 8VC, Amino Collective, British Business Bank, Outsized, Pillar VC, SCVC, We Venture Capital, WS Investment Companysource: nif.fund
- Nearest station
- White City, 250 m
- Visas
- Licensed visa sponsor, listed as Portal Biotech Limitedsource: gov.uk
Verified 9 Oct 2026. How we verify · Suggest a fix
Same building
3 more companies on the map list this office address.